BioCentury | Dec 5, 2006
Financial News

Cylex raises $18.4 million

...joined existing investors Cahn Medical Technologies; Calvert Venture Fund; Chesapeake Emerging Opportunities; Early Stage Enterprises; NJTC Venture Fund...
BioCentury | Mar 21, 2005
Finance

Ebb & Flow

...48.9% prior to the IPO); MXL Industries (19.8%); Wheatley Partners (11.5%); Psilos Group (6.7%); and NJTC Venture Fund...
BioCentury | Dec 20, 2004
Company News

Cylex board of directors update

...Cylex Inc. , Columbia, Md. Business: Diagnostic Appointed: Robert Chefitz, a general partner in the NJTC Venture Fund...
BioCentury | Aug 23, 2004
Finance

Follow the money

...fall. Psilos Group Managers led the round. Other investors included Sanders Morris; Wheatley Partners; and NJTC Venture Fund...
BioCentury | Aug 20, 2004
Financial News

Valera raises $11.5 million

...C round led by Psilos Group Managers. Other investors included Sanders Morris; Wheatley Partners; and NJTC Venture Fund...
BioCentury | Nov 17, 2003
Company News

Linguagen board of directors update

...Linguagen Corp. , Cranbury, N.J. Business: Other Appointed: Robert Chefitz, general partner of NJTC Venture Fund; David Patchen...
BioCentury | Jun 9, 2003
Finance

Ebb & Flow

...Other investors were Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures; Technology Partners and NJTC Venture Fund...
BioCentury | Jun 9, 2003
Financial News

EpiGenesis raises $23 million

...Other investors included Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures; Technology Partners; and NJTC Venture Fund...
Items per page:
1 - 8 of 8
BioCentury | Dec 5, 2006
Financial News

Cylex raises $18.4 million

...joined existing investors Cahn Medical Technologies; Calvert Venture Fund; Chesapeake Emerging Opportunities; Early Stage Enterprises; NJTC Venture Fund...
BioCentury | Mar 21, 2005
Finance

Ebb & Flow

...48.9% prior to the IPO); MXL Industries (19.8%); Wheatley Partners (11.5%); Psilos Group (6.7%); and NJTC Venture Fund...
BioCentury | Dec 20, 2004
Company News

Cylex board of directors update

...Cylex Inc. , Columbia, Md. Business: Diagnostic Appointed: Robert Chefitz, a general partner in the NJTC Venture Fund...
BioCentury | Aug 23, 2004
Finance

Follow the money

...fall. Psilos Group Managers led the round. Other investors included Sanders Morris; Wheatley Partners; and NJTC Venture Fund...
BioCentury | Aug 20, 2004
Financial News

Valera raises $11.5 million

...C round led by Psilos Group Managers. Other investors included Sanders Morris; Wheatley Partners; and NJTC Venture Fund...
BioCentury | Nov 17, 2003
Company News

Linguagen board of directors update

...Linguagen Corp. , Cranbury, N.J. Business: Other Appointed: Robert Chefitz, general partner of NJTC Venture Fund; David Patchen...
BioCentury | Jun 9, 2003
Finance

Ebb & Flow

...Other investors were Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures; Technology Partners and NJTC Venture Fund...
BioCentury | Jun 9, 2003
Financial News

EpiGenesis raises $23 million

...Other investors included Investor Growth Capital; Boston Millennia Partners; Merrill Lynch Ventures; Technology Partners; and NJTC Venture Fund...
Items per page:
1 - 8 of 8